These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9194496)

  • 1. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
    Watanabe Y; Dvorak HF
    Exp Cell Res; 1997 Jun; 233(2):340-9. PubMed ID: 9194496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
    Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.
    Pepper MS; Mandriota SJ
    Exp Cell Res; 1998 Jun; 241(2):414-25. PubMed ID: 9637783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
    Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
    Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM; Dvorak HF; Brock TA; Senger DR
    Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S; Datta K; Mukhopadhyay D
    Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
    Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis.
    Vasile E; Tomita Y; Brown LF; Kocher O; Dvorak HF
    FASEB J; 2001 Feb; 15(2):458-66. PubMed ID: 11156961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.